Further support of the importance of m6A modifications in cancer metabolism and the crosstalk between m6A modification and lncRNA was seen with LncRNA FGF13-AS1 in breast cancer, in which it exhibited a tumor suppressor function reducing MYC stability by directly disrupting MYC-IGF2BP2 binding. The gene discussed is MYC; the disease is breast carcinoma.